Nasdaq · CIK 0001269026
SINT Sintx Technologies, Inc.
Insider trading from SEC Form 4. Last filing Apr 14, 2026. Close $2.11 on Oct 9, 2026, +51% from the 52-week low and -51% from the high.
Sintx Technologies, Inc. (SINT) has 21 SEC Form 4 filings on file from 7 insiders, the latest filed on Apr 14, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
15 open-market trades have been scored at SINT. The newest: Christopher Michael Lyons (director) bought $24k of stock on Feb 25, 2026, filed Mar 10, 2026, scored 46 (moderate). The largest of the 15 shown: Gregg R. Honigblum (Chief Investment Officer) bought $255k on Dec 5, 2025, scored 47 (moderate). 3 insiders bought within 14 days of each other around Feb 25, 2026.
SINT closed at $2.11 on Oct 9, 2026, 51% above its 52-week low and 51% below its 52-week high.
1 Form 144 notice of planned sales is on file, the latest filed Feb 27, 2025.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Sintx Technologies, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 46Moderate | Christopher Michael Lyons director buy | $24k 8,292 shares | - | +70% from low-47% from high | |
| 44Moderate | Jay M Moyes director buy | $2,910 1,000 shares | +33% | +70% from low-47% from high | |
| 44Moderate | Mark Lewis Anderson director buy | $9,060 3,000 shares | +20% | +73% from low-46% from high | |
| 30Weak | Gregg R. Honigblum Chief Investment Officer buy | $35k 8,200 shares | +4% | +143% from low-24% from high | |
| 47Moderate | Gregg R. Honigblum Chief Investment Officer buy | $255k 65,000 shares | +88% | +133% from low-27% from high | |
| 36Weak | Gregg R. Honigblum Chief Investment Officer buy | $32k 10,000 shares | +16% | +89% from low-48% from high | |
| 44Moderate | Eric K. Olson President and CEO buy | $20k 5,800 shares | +23% | +94% from low-47% from high | |
| 60Notable | Gregg R. Honigblum Chief Investment Officer buy | $185k 50,000 shares | +357% | +120% from low-40% from high | |
| 46Moderate | Jay M Moyes director buy | $11k 3,000 shares | - | +120% from low-40% from high | |
| 64Notable | Eric K. Olson President and CEO buy | $37k 10,475 shares | +72% | +102% from low-45% from high | |
| 36Weak | Mark Lewis Anderson director buy | $33k 10,000 shares | +200% | - | |
| 46Moderate | Mark Lewis Anderson director buy | $12k 5,000 shares | - | +57% from low-57% from high | |
| 54Moderate | Gregg R. Honigblum Chief Strategy Officer buy | $7,160 4,000 shares | +40% | +1% from low-72% from high | |
| 56Moderate | Gregg R. Honigblum Chief Strategy Officer buy | $18k 10,000 shares | - | +1% from low-72% from high | |
| 71Notable | Eric K. Olson President and CEO buy | $28k 14,500 shares | - | +1% from low-72% from high |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 27, 2025 | Tate Kerry 10% Stockholder | 157,249 11.71% of outstanding | $689k | Feb 27, 2025 | none |
Transactions
The newest 50 of 56 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | Robert Ryan Elmore President | AGrant or award Common Stock | +4,910 | $2.89 | $14k | 4,910 | Apr 14, 2026 |
| Mar 16, 2026 | Robert Ryan Elmore President | AGrant or award Restricted Stock Unitsderivative | +107,143 | $0.00 | $0 | 107,143 | Mar 18, 2026 |
| Feb 25, 2026 | Christopher Michael Lyons director | POpen-market purchase Common Stock | +758 | $2.96 | $2,244 | 758 | Mar 10, 2026 |
| Mar 2, 2026 | Christopher Michael Lyons director | POpen-market purchase Common Stock | +7,534 | $2.90 | $22k | 8,292 | Mar 10, 2026 |
| Feb 23, 2026 | Jay M Moyes director | POpen-market purchase Common Stock | +1,000 | $2.91 | $2,910 | 4,000 | Feb 25, 2026 |
| Feb 18, 2026 | Mark Lewis Anderson director | POpen-market purchase Common Stock | +3,000 | $3.02 | $9,060 | 18,000 | Feb 19, 2026 |
| Feb 6, 2026 | Eric K. Olson Chairman, President and CEO | AGrant or award Restricted Stock Unitsderivative | +100,000 | $0.00 | $0 | 160,000 | Feb 10, 2026 |
| Feb 6, 2026 | Kevin Trask Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +60,000 | $0.00 | $0 | 100,000 | Feb 10, 2026 |
| Feb 6, 2026 | Gregg R. Honigblum Chief Investment Officer | AGrant or award Restricted Stock Unitsderivative | +75,000 | $0.00 | $0 | 133,000 | Feb 10, 2026 |
| Dec 8, 2025 | Gregg R. Honigblum Chief Investment Officer | POpen-market purchase Common Stock | +3,200 | $4.28 | $14k | 196,067 | Dec 9, 2025 |
| Dec 8, 2025 | Gregg R. Honigblum Chief Investment Officer | POpen-market purchase Common Stock | +5,000 | $4.24 | $21k | 201,067 | Dec 9, 2025 |
| Dec 5, 2025 | Gregg R. Honigblum Chief Investment Officer | POpen-market purchase Common Stock | +5,000 | $3.95 | $20k | 79,000 | Dec 8, 2025 |
| Dec 5, 2025 | Gregg R. Honigblum Chief Investment Officer | POpen-market purchase Common Stock | +5,000 | $3.94 | $20k | 84,000 | Dec 8, 2025 |
| Dec 5, 2025 | Gregg R. Honigblum Chief Investment Officer | POpen-market purchase Common Stock | +5,000 | $4.00 | $20k | 89,000 | Dec 8, 2025 |
| Dec 5, 2025 | Gregg R. Honigblum Chief Investment Officer | POpen-market purchase Common Stock | +5,000 | $4.07 | $20k | 94,000 | Dec 8, 2025 |
| Dec 5, 2025 | Gregg R. Honigblum Chief Investment Officer | POpen-market purchase Common Stock | +5,000 | $4.02 | $20k | 99,000 | Dec 8, 2025 |
| Dec 5, 2025 | Gregg R. Honigblum Chief Investment Officer | POpen-market purchase Common Stock | +5,000 | $3.94 | $20k | 104,000 | Dec 8, 2025 |
| Dec 5, 2025 | Gregg R. Honigblum Chief Investment Officer | POpen-market purchase Common Stock | +5,000 | $3.91 | $20k | 109,000 | Dec 8, 2025 |
| Dec 5, 2025 | Gregg R. Honigblum Chief Investment Officer | POpen-market purchase Common Stock | +5,000 | $3.91 | $20k | 114,000 | Dec 8, 2025 |
| Dec 5, 2025 | Gregg R. Honigblum Chief Investment Officer | POpen-market purchase Common Stock | +5,000 | $3.91 | $20k | 119,000 | Dec 8, 2025 |
| Dec 5, 2025 | Gregg R. Honigblum Chief Investment Officer | POpen-market purchase Common Stock | +5,000 | $3.88 | $19k | 124,000 | Dec 8, 2025 |
| Dec 5, 2025 | Gregg R. Honigblum Chief Investment Officer | POpen-market purchase Common Stock | +5,000 | $3.86 | $19k | 129,000 | Dec 8, 2025 |
| Dec 5, 2025 | Gregg R. Honigblum Chief Investment Officer | POpen-market purchase Common Stock | +5,000 | $3.91 | $20k | 134,000 | Dec 8, 2025 |
| Dec 5, 2025 | Gregg R. Honigblum Chief Investment Officer | POpen-market purchase Common Stock | +5,000 | $3.77 | $19k | 139,000 | Dec 8, 2025 |
| Dec 5, 2025 | Gregg R. Honigblum Chief Investment Officer | AGrant or award Common Stock | +53,867 | $0.00 | $0 | 192,867 | Dec 8, 2025 |
| Nov 7, 2025 | Gregg R. Honigblum Chief Investment Officer | POpen-market purchase Common Stock | +5,000 | $3.20 | $16k | 69,000 | Nov 10, 2025 |
| Nov 7, 2025 | Gregg R. Honigblum Chief Investment Officer | POpen-market purchase Common Stock | +5,000 | $3.18 | $16k | 74,000 | Nov 10, 2025 |
| Oct 20, 2025 | Eric K. Olson President and CEO | POpen-market purchase Common Stock | +5,800 | $3.40 | $20k | 30,775 | Oct 21, 2025 |
| Sep 4, 2025 | Kevin Trask Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +70,000 | $0.00 | $0 | 90,000 | Sep 5, 2025 |
| Aug 26, 2025 | Jay M Moyes director | POpen-market purchase Common Stock | +3,000 | $3.59 | $11k | 3,000 | Aug 27, 2025 |
| Aug 26, 2025 | Gregg R. Honigblum Chief Investment Officer | POpen-market purchase Common Stock | +5,000 | $3.60 | $18k | 19,000 | Aug 27, 2025 |
| Aug 26, 2025 | Gregg R. Honigblum Chief Investment Officer | POpen-market purchase Common Stock | +5,000 | $3.66 | $18k | 24,000 | Aug 27, 2025 |
| Aug 26, 2025 | Gregg R. Honigblum Chief Investment Officer | POpen-market purchase Common Stock | +5,000 | $3.70 | $19k | 29,000 | Aug 27, 2025 |
| Aug 26, 2025 | Gregg R. Honigblum Chief Investment Officer | POpen-market purchase Common Stock | +5,000 | $3.68 | $18k | 34,000 | Aug 27, 2025 |
| Aug 26, 2025 | Gregg R. Honigblum Chief Investment Officer | POpen-market purchase Common Stock | +5,000 | $3.74 | $19k | 39,000 | Aug 27, 2025 |
| Aug 26, 2025 | Gregg R. Honigblum Chief Investment Officer | POpen-market purchase Common Stock | +5,000 | $3.73 | $19k | 44,000 | Aug 27, 2025 |
| Aug 26, 2025 | Gregg R. Honigblum Chief Investment Officer | POpen-market purchase Common Stock | +5,000 | $3.69 | $18k | 49,000 | Aug 27, 2025 |
| Aug 26, 2025 | Gregg R. Honigblum Chief Investment Officer | POpen-market purchase Common Stock | +5,000 | $3.72 | $19k | 54,000 | Aug 27, 2025 |
| Aug 26, 2025 | Gregg R. Honigblum Chief Investment Officer | POpen-market purchase Common Stock | +5,000 | $3.75 | $19k | 59,000 | Aug 27, 2025 |
| Aug 26, 2025 | Gregg R. Honigblum Chief Investment Officer | POpen-market purchase Common Stock | +5,000 | $3.73 | $19k | 64,000 | Aug 27, 2025 |
| Aug 22, 2025 | Eric K. Olson President and CEO | POpen-market purchase Common Stock | +3,500 | $3.37 | $12k | 18,000 | Aug 25, 2025 |
| Aug 22, 2025 | Eric K. Olson President and CEO | POpen-market purchase Common Stock | +5,000 | $3.69 | $18k | 23,000 | Aug 25, 2025 |
| Aug 22, 2025 | Eric K. Olson President and CEO | POpen-market purchase Common Stock | +775 | $3.64 | $2,821 | 23,775 | Aug 25, 2025 |
| Aug 22, 2025 | Eric K. Olson President and CEO | POpen-market purchase Common Stock | +1,200 | $3.67 | $4,404 | 24,975 | Aug 25, 2025 |
| Jun 18, 2025 | Mark Lewis Anderson director | POpen-market purchase Common Stock | +10,000 | $3.30 | $33k | 15,000 | Jun 23, 2025 |
| Apr 24, 2025 | Mark Lewis Anderson director | POpen-market purchase Common Stock | +5,000 | $2.36 | $12k | 5,000 | May 14, 2025 |
| Apr 22, 2025 | Gregg R. Honigblum Chief Strategy Officer | POpen-market purchase Common Stock | +4,000 | $1.79 | $7,160 | 14,000 | May 1, 2025 |
| Apr 22, 2025 | Eric K. Olson President and CEO | POpen-market purchase Common Stock | +236 | $1.73 | $408 | 236 | Apr 30, 2025 |
| Apr 22, 2025 | Gregg R. Honigblum Chief Strategy Officer | POpen-market purchase Common Stock | +3,000 | $1.76 | $5,280 | 3,000 | Apr 30, 2025 |
| Apr 23, 2025 | Eric K. Olson President and CEO | POpen-market purchase Common Stock | +3,000 | $1.95 | $5,852 | 3,236 | Apr 30, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Mark Lewis Andersondirector
- Robert Ryan ElmorePresident
- Gregg R. HonigblumChief Investment Officer
- Christopher Michael Lyonsdirector
- Jay M Moyesdirector
- Eric K. OlsonChairman, President and CEO
- Kevin TraskChief Financial Officer
Questions about SINT
Answered from the filings on this page, as of the latest one.
Are insiders buying SINT?
No. In the last 90 days no insider at Sintx Technologies, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade SINT on the open market?
Christopher Michael Lyons (director) bought $24k of SINT on Feb 25, 2026 and filed the Form 4 on Mar 10, 2026. InsiderTell scored 46 (moderate), with 3 insiders on the same side within 14 days.
How many insiders file Form 4 at Sintx Technologies, Inc.?
7 people have filed a Form 4 at Sintx Technologies, Inc., among them Mark Lewis Anderson (director), Robert Ryan Elmore (President), Gregg R. Honigblum (Chief Investment Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.